Cytodyn Competitors and Similar CompaniesClear all
Cytodyn's competitors and similar companies include CNS Pharmaceuticals, Clovis Oncology, Nektar Therapeutics and Ascendis Pharma.
 Cytodyn CytoDyn is a biotechnology company developing therapies to address cancer, HIV, and other autoimmune diseases. |  CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. |  Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | ||
Founding Date | Founding Date 2002 | Founding Date 2017 | Founding Date 2009 | Founding Date 1990 | Founding Date 2007 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Vancouver, US HQ | Locations Houston, US HQ | Locations San Francisco, US HQ Hyderabad, IN Huntsville, US | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US | |
Employees | Employees 10 | Employees 433% increase | Employees 4843% increase | Employees 61821% increase | Employees 1,017 |
Valuation ($) | Valuation ($) 164.2 m | Valuation ($) 4.7 m | Valuation ($) 10.6 m | Valuation ($) 233.8 m | Valuation ($) 7.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $55.2m (FY, 2025) | Revenue (est.) €720.1m (FY, 2025) |
Net income | Net income $3.7m (FY, 2025) | Net income ($15.9m) (FY, 2025) | Net income ($264.5m) (FY, 2021) | Net income ($164.1m) (FY, 2025) | Net income (€228m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 357m | Total funding raised $ 45m | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
CNS Pharmaceuticals
HQ
Houston, US
Employees
4↑ 33% increase
CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors.
View companyClovis Oncology
HQ
Boulder, US
Employees
484↑ 3% increase
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View company
Nektar Therapeutics
HQ
San Francisco, US
Employees
618↑ 21% increase
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
View companyAscendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company